Oncorus is a pre-clinical stage biotechnology company developing innovative and impactful, next-generation oncolytic HSV products with unprecedented potential to recruit all arms of immune system to treat solid tumors.

Register for Details

For more details on financing and valuation for Oncorus, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

What is Oncorus's ticker symbol?


What is Oncorus's stock price?

0.12055 as of 6/20/23

Learn more about Oncorus

Forge green plus iconForge green minus icon

What is Oncorus funding to date?

Oncorus has raised $140.5MM to date.
Forge green plus iconForge green minus icon

When was Oncorus founded?

Oncorus was founded in 2015.
Updated on: Jun 12, 2022